Cargando…

High-Sensitivity Cardiac Troponin T Is a Risk Factor for Major Adverse Cardiovascular Events and All-Cause Mortality: A 9.5-Year Follow-Up Study

BACKGROUND: The relationship between high-sensitivity cardiac troponin T (hs-cTnT) and different cardiovascular events has been observed in several large community studies, and the results have been controversial. However, there is currently no cross-sectional or longitudinal follow-up study on hs-c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xiaona, Wang, Peiqi, Cao, Ruihua, Yang, Xu, Xiao, Wenkai, Zhang, Yun, Sheng, Li, Ye, Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413051/ https://www.ncbi.nlm.nih.gov/pubmed/34484819 http://dx.doi.org/10.1155/2021/6647987

Ejemplares similares

The predictive value of arterial stiffness on major adverse cardiovascular events in individuals with mildly impaired renal function
por: Han, Jie, et al.
Publicado: (2016)

Association of high-sensitivity cardiac troponin T with mortality and cardiovascular events in a community-based prospective study in Beijing
por: Xiao, Wenkai, et al.
Publicado: (2017)

TROPONIN-I PREDICTS MAJOR ADVERSE CARDIOVASCULAR EVENTS AND RISK OF MORTALITY IN COVID-19 PATIENTS
por: Patel, Chirag, et al.
Publicado: (2021)

Prognostic value of high-sensitivity cardiac troponin for major adverse cardiovascular events in patients with diabetes: a systematic review and meta-analysis
por: Song, Tiange, et al.
Publicado: (2023)

Correlation between small and dense low‐density lipoprotein cholesterol and cardiovascular events in Beijing community population
por: Wang, Xiaona, et al.
Publicado: (2021)

Multicenter analysis to assess risk of major adverse cardiac events in patients undergoing high‐sensitivity troponin testing in the emergency department
por: Serven, Victoria, et al.
Publicado: (2023)

High-Sensitivity Cardiac Troponin Predicts Major Cardiovascular Events in Diabetic Patients With Critical Limb Ischemia and Foot Lesions
por: Cimaglia, Paolo, et al.
Publicado: (2021)

Associations of High‐Sensitivity Troponin and Natriuretic Peptide Levels With Serious Adverse Events in SPRINT
por: Ascher, Simon B., et al.
Publicado: (2022)

Elevated level of high-sensitivity cardiac troponin I as a predictor of adverse cardiovascular events in patients with heart failure with preserved ejection fraction
por: Hu, Hongyu, et al.
Publicado: (2023)

Urine Albumin Excretion Is Associated with Cardiac Troponin T Detected with a Highly Sensitive Assay in a Community-Based Population
por: Xiao, Wenkai, et al.
Publicado: (2015)

5(th) generation vs 4(th) generation troponin T in predicting major adverse cardiovascular events and all-cause mortality in patients hospitalized for non-cardiac indications: A cohort study
por: Gupta, Vedant, et al.
Publicado: (2021)

The prognostic value of cardiac troponin for 60 day mortality and major adverse events in COVID-19 patients
por: Ruge, Max, et al.
Publicado: (2021)

Association Between Heart Rate and Major Adverse Cardiovascular Events Among 9,991 Hypertentive Patients: A Multicenter Retrospective Follow-Up Study
por: Sun, Ningling, et al.
Publicado: (2021)

Natriuretic Peptides and Troponins to Predict Cardiovascular Events in Patients Undergoing Major Non-Cardiac Surgery
por: Perrone, Marco Alfonso, et al.
Publicado: (2022)

Association Between Circulating Proprotein Convertase Subtilisin/Kexin Type 9 and Major Adverse Cardiovascular Events, Stroke, and All-Cause Mortality: Systemic Review and Meta-Analysis
por: Zhou, Yimo, et al.
Publicado: (2021)

Urine High-Sensitivity Troponin I Predict Incident Cardiovascular Events in Patients with Diabetes Mellitus
por: Chen, Ju-Yi, et al.
Publicado: (2020)

Combined evaluation of coronary artery disease and high-sensitivity cardiac troponin T for prediction of adverse events in patients with hypertrophic cardiomyopathy
por: Liao, Hang, et al.
Publicado: (2021)

Depressive symptoms and major adverse cardiovascular events: 12-month follow-up in patients undergoing angiography
por: Dadkhah-Tirani, Heidar, et al.
Publicado: (2020)

Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis
por: Mal, Kheraj, et al.
Publicado: (2020)

Prediabetes as a risk factor for major adverse cardiovascular events
por: Mando, Ramy, et al.
Publicado: (2021)

Association of Prior Intracerebral Hemorrhage With Major Adverse Cardiovascular Events
por: Gaist, David, et al.
Publicado: (2022)

Comparison of HEAR and HEART Scores for Major Adverse Cardiovascular Events
por: Uyan, Umut
Publicado: (2023)

Major adverse cardiovascular events and hyperuricemia during tuberculosis treatment
por: Shin, Hong-Joon, et al.
Publicado: (2023)

The Relationship Between Cardiac Troponin in People Hospitalised for Exacerbation of COPD and Major Adverse Cardiac Events (MACE) and COPD Readmissions
por: Kallis, Constantinos, et al.
Publicado: (2023)

Cardiovascular Risk Markers and Major Adverse Cardiovascular Events in Psoriatic Arthritis Patients
por: Peluso, Rosario, et al.
Publicado: (2018)

Angiopoietin-2 as a Prognostic Biomarker of Major Adverse Cardiovascular Events and All-Cause Mortality in Chronic Kidney Disease
por: Tsai, Yi-Chun, et al.
Publicado: (2015)

Major adverse cardiovascular events and all-cause mortality after emergency general surgery among kidney failure patients
por: Anderson, Benjamin, et al.
Publicado: (2022)

Association of Pioglitazone With Major Adverse Cardiovascular Events, All-Cause Mortality, and Heart Failure Hospitalizations: A Systematic Review
por: Sheikh, Ibrahimkhalil M, et al.
Publicado: (2023)

Achieving the 95 95 95 targets for all: A pathway to ending AIDS
por: Frescura, Luisa, et al.
Publicado: (2022)

Prognostic performance of preoperative cardiac troponin and perioperative changes in cardiac troponin for the prediction of major adverse cardiac events and mortality in noncardiac surgery: A systematic review and meta-analysis
por: Humble, Caroline A. S., et al.
Publicado: (2019)

Major Adverse Cardiovascular Events in Treated Periodontitis: A Population-Based Follow-Up Study from Taiwan
por: Chou, Shing-Hsien, et al.
Publicado: (2015)

Major adverse cardiovascular event (MACE) after percutaneous coronary intervention in one-year follow-up study
por: Farshidi, Hossein, et al.
Publicado: (2018)

Impact of diabesity phenotype on cardiovascular diseases, major cardiovascular events and all-cause mortality
por: Mehrabani-Zeinabad, Kamran, et al.
Publicado: (2023)

Relationship between lung function impairment, hypertension, and major adverse cardiovascular events: A 10‐year follow‐up study
por: Wang, Jiaqi, et al.
Publicado: (2021)

Heterogeneous plaque–lumen geometry is associated with major adverse cardiovascular events
por: Gu, Sophie Z, et al.
Publicado: (2023)

Joint effect of highly-sensitive cardiac troponin T and ankle-brachial index on incident cardiovascular events: The MESA and CHS
por: Tedla, Yacob G., et al.
Publicado: (2023)

High sensitivity troponins and conventional troponins at the bedside
por: Bhoi, Sanjeev, et al.
Publicado: (2014)

Adherence to Guideline‐Recommended Therapy Is Associated With Decreased Major Adverse Cardiovascular Events and Major Adverse Limb Events Among Patients With Peripheral Arterial Disease
por: Armstrong, Ehrin J., et al.
Publicado: (2014)

Effects of high dose atorvastatin before elective percutaneous coronary intervention on highly sensitive troponin T and one year major cardiovascular events; a randomized clinical trial()
por: Pourhosseini, HamidReza, et al.
Publicado: (2019)

Association of lipoprotein(a) and major adverse cardiovascular events in patients with percutaneous coronary intervention
por: Chen, Zhihao, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_kp0feivua50b4cn5d5gicd84ut